Clinical Trials
21 trialsNCT04928846 2026-05-27
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
AbbVie
Phase 3 Recruiting
NCT05256225 2026-05-27
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
National Cancer Institute (NCI)
Phase 3 Recruiting
NCT07410117 2026-05-27
ROXI-CAT-I
Regeneron Pharmaceuticals
Phase 3 Recruiting
NCT05445778 2026-05-26
GLORIOSA
AbbVie
Phase 3 Active not recruiting
NCT05920356 2026-05-22
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Amgen
Phase 3 Recruiting
NCT03194893 2026-05-20
A Rollover Study of Alectinib in Patients With Anaplastic Lymphoma Kinase (ALK)-Positive or Rearranged During Transfection (RET)-Positive Cancer
Hoffmann-La Roche
Phase 3 Active not recruiting
NCT06768164 2026-05-20
BYQoL-GC
Assistance Publique - Hôpitaux de Paris
Phase 3 Recruiting
NCT05303532 2026-05-19
ROSY-D
AstraZeneca
Phase 3 Enrolling by invitation
NCT06119581 2026-05-19
SUNRAY-01
Eli Lilly and Company
Phase 3 Recruiting
NCT06127654 2026-05-19
VITaL
University of Sydney
Phase 3 Recruiting
NCT06881992 2026-05-18
Tumor HI
Rezolute
Phase 3 Recruiting
NCT06088290 2026-05-15
SaLuDo
PharmaMar
Phase 3 Active not recruiting
NCT06691984 2026-05-15
Phase 3 Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Participants With Progressive Metastatic Castration-Resistant Prostate Cancer (XALute)
Amgen
Phase 3 Active not recruiting
NCT07590505 2026-05-15
ULTIMO
Cancer Research Antwerp
Phase 3 Completed
NCT03844048 2026-05-13
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
AbbVie
Phase 3 Active not recruiting
NCT07583979 2026-05-13
EAST-ALIGN
National Cancer Centre, Singapore
Phase 3 Not yet recruiting
NCT05862285 2026-05-12
UmbrellaMAX
Hoffmann-La Roche
Phase 3 Recruiting
NCT07566156 2026-05-11
EV-309
Astellas Pharma Inc
Phase 3 Recruiting
NCT03979014 2026-05-06
NOVEL
Imperial College London
Phase 3 Completed
NCT06191744 2026-05-06
EPCOREâ„¢FL-2
Genmab
Phase 3 Recruiting
NCT03504397 2026-05-04
Spotlight
Astellas Pharma Inc
Phase 3 Active not recruiting